IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Return on Equity [ROE] (2019 - 2025)

Updated

IRulya Therapeutics (IRLA) reported Return on Equity [ROE] of -890.64% for Q3 2025, down 774.73 percentage points from -115.92% a year earlier and down 567.20 percentage points from the prior quarter.

Analysis

IRulya Therapeutics (IRLA) Return on Equity [ROE] (2019 - 2025) Analysis & Trends

For FY2024, IRulya Therapeutics posted Return on Equity [ROE] of -98.63%, down 64.83 percentage points from FY2023.

  • Return on Equity [ROE] has a five-year change of -9.37 percentage points (FY2019 to FY2024).
  • By year, Return on Equity [ROE] came in at -33.81% in FY2023 (+13.33 pp), -47.14% in FY2022 and -53.42% in FY2020 (+35.85 pp).
  • The Q3 2025 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q2 2019.
  • Year over year, Return on Equity [ROE] has now declined in each of the last six quarters, with an average year-over-year change of -181.56 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q3 2022 (a gain of 82.31 percentage points); the low point was Q3 2025 (a drop of 774.73 percentage points).
  • Per Business Quant data, the three quarters before Q3 2025 came in at -323.44% (Q2 2025), -249.18% (Q1 2025) and -151.38% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 19.33%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 5.63%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 21.60%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 72.13%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -31.17%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 4.66%
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -890.64%
Jun 30, 2025 -323.44%
Mar 31, 2025 -249.18%
Dec 31, 2024 -151.38%
Sep 30, 2024 -115.92%
Jun 30, 2024 -87.70%
Mar 31, 2024 -38.03%
Dec 31, 2023 -37.31%
Sep 30, 2023 -32.97%
Jun 30, 2023 -34.55%
Mar 31, 2023 -44.31%
Dec 31, 2022 -50.37%
Sep 30, 2022 18.90%
Jun 30, 2022 6.09%
Mar 31, 2022 1.28%
Sep 30, 2021 -63.41%
Jun 30, 2021 -58.21%
Mar 31, 2021 -50.35%
Dec 31, 2020 -42.66%
Sep 30, 2020 -34.91%
API Access

IRulya Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IRLA&period=max&api_key=YOUR_API_KEY